Guangzhou LBP Medicine Science & Technology Second Quarter 2024 Earnings: EPS: CN¥0.081 (vs CN¥0.11 in 2Q 2023)

Simply Wall St · 08/31 01:25

Guangzhou LBP Medicine Science & Technology (SHSE:688393) Second Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥126.6m (up 5.3% from 2Q 2023).
  • Net income: CN¥8.37m (down 19% from 2Q 2023).
  • Profit margin: 6.6% (down from 8.6% in 2Q 2023). The decrease in margin was driven by higher expenses.
  • EPS: CN¥0.081 (down from CN¥0.11 in 2Q 2023).
earnings-and-revenue-history
SHSE:688393 Earnings and Revenue History August 31st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Guangzhou LBP Medicine Science & Technology shares are up 8.0% from a week ago.

Risk Analysis

You should learn about the 2 warning signs we've spotted with Guangzhou LBP Medicine Science & Technology (including 1 which is significant).